4D Molecular Therapeutics, Inc. (FDMT) Debt by Year
4D Molecular Therapeutics, Inc. carried $0 in long-term debt against $60.2M in cash and equivalents at the end of fiscal year 2025. The table below carries 7 fiscal years, from 2019 to 2025, and the quarters 4D Molecular Therapeutics, Inc. has filed alongside them.
Annual figures, oldest first. Point at a bar to read its period.
FDMT Debt & Cash by Fiscal Year
Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
FDMT Debt & Cash by Quarter
Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q | Q2'2410-Q | Q1'2410-Q | Q4'2310-K | Q3'2310-Q |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Long-Term Debt | $19.6M | N/A | $0 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Cash & Equivalents | $70.4M-8.8% | $72.5M-45.7% | $60.2M-100.0% | $48.6M-74.1% | $77.2M-59.2% | $133.5M-51.5% | $149.3B+59848.3% | $187.5M-32.0% | $189.1M-20.0% | $275.6M+250.8% | $249.1M+375.8% | $275.7M+154.6% |
What long-term debt means
Long-term debt is borrowing that falls due more than a year out, and the cash line beside it is what the company held on the same balance sheet date.
More 4D Molecular Therapeutics, Inc. financials
Frequently Asked Questions
What was 4D Molecular Therapeutics, Inc.'s long-term debt in fiscal year 2025?
4D Molecular Therapeutics, Inc. carried $0 in long-term debt against $60.2M in cash and equivalents at the end of fiscal year 2025.
What was 4D Molecular Therapeutics, Inc.'s long-term debt in the most recent quarter?
4D Molecular Therapeutics, Inc. (FDMT) reported $19.6M in long-term debt in Q2 2026.
What does long-term debt mean on a financial statement?
Long-term debt is borrowing that falls due more than a year out, and the cash line beside it is what the company held on the same balance sheet date. This page lists what 4D Molecular Therapeutics, Inc. (FDMT) reported on that line in every period on record.